Successful treatment of disseminated granuloma annulare with adalimumab
Rosmarin, D.; LaRaia, A.; Schlauder, S.; Gottlieb, A.B.
Journal of Drugs in Dermatology Jdd 8(2): 169-171
2009
ISSN/ISBN: 1545-9616 PMID: 19213233 Document Number: 15078
A 61-year-old female with a 4-year history of disseminated granuloma annulare was successfully treated with the antitumor necrosis factor (TNF)-alpha antibody, adalimumab. The patient had failed high potency topical glucocorticoids, hydroxychloroquine, and narrow-band ultraviolet light (UV)-B phototherapy. Anti-TNF-alpha therapy may be a therapeutic option in patients with disseminated granuloma annulare poorly controlled with conventional medications.
Document emailed within 1 workday
